Investigator-sponsored study funded by Glaucoma UK and the HSC R&D Division expands ART27.13’s clinical potential into ophthalmologyFirst ...
Explore the latest research on glaucoma treatment and the role of immune cells in eye pressure regulation for better outcomes ...
Add Yahoo as a preferred source to see more of our stories on Google. The scientists suggest that agmatine and thiamine could be used as biomarkers for earlier detection of glaucoma, allowing doctors ...
Artelo Biosciences (NASDAQ:ARTL) is expanding its development pipeline into ophthalmology with a new clinical study ...
Scientists found immune cells (resident macrophages) help regulate eye pressure by keeping the eye’s drainage system clear.
The Independent on MSN
AI could revolutionise glaucoma detection. Six things you should know
AI could revolutionise glaucoma detection. Here’s 6 things everyone should know - Age and family history are significant risk ...
New York City, New York (CBS) - Glaucoma is one of the leading causes of blindness in the U.S. And doctors are stressing why it’s so important to get tested and treated early for the disease.
REDWOOD CITY, Calif., Feb. 25, 2026 /PRNewswire/ -- Avisi Technologies, Inc., an ophthalmic medical device company advancing novel, sight-saving technologies, announces the closing of $10.7M in new ...
Glaucoma develops when fluid inside the eye doesn’t drain properly, causing pressure to build up over time and damage the optic nerve ...
Please provide your email address to receive an email when new articles are posted on . A renewed focus on glaucoma comes with each new year, as January is Glaucoma Awareness Month. Glaucoma has been ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results